Medtronic plc, a global leader in healthcare technology, today announced a strategic agreement to distribute the advanced Dragonfly™* pancreaticobiliary system from Dragonfly Endoscopy, Inc. in the United States. This innovative platform introduces significant enhancements in pancreaticobiliary endoscopy — a field where procedural standards have remained largely unchanged for decades.

美敦力公司（Medtronic plc），一家全球领先的医疗技术公司，今天宣布了一项战略协议，将在美国分销Dragonfly Endoscopy公司的先进Dragonfly™*胰胆系统。这一创新平台在胰胆内窥镜领域引入了显著的改进——该领域的操作标准几十年来基本保持不变。

Financial terms of the agreement were not disclosed..

协议的财务条款未被披露。

The Dragonfly™* system uniquely addresses critical clinical limitations seen in traditional cholangioscopy — an endoscopic method for direct visualization and therapeutic intervention in the bile and pancreatic ducts — offering healthcare providers enhanced visualization

Dragonfly™* 系统独特地解决了传统胆道镜检查中出现的关键临床限制——这是一种用于胆管和胰管直接可视化及治疗干预的内窥镜方法——为医疗保健提供者提供了增强的可视化功能。

, maneuverability

机动性

, as well as diagnostic and therapeutic capabilities

以及诊断和治疗能力

— potentially increasing procedure adoption and enhancing patient care.

——可能增加手术采用率并提高患者护理质量。

The Dragonfly™* pancreaticobiliary endoscope features a fully rotatable, highly flexible shaft

龙蝇™*胰胆管内窥镜具有完全可旋转、高度灵活的轴

and a 42% larger working channel diameter vs. the current standard, all within the same compact scope profile.

比当前标准的工作通道直径增大42%，且保持在同一紧凑的镜体轮廓内。

These advances allow for the utilization of more robust and durable Electrohydraulic Lithotripsy (EHL) probes

这些进展使得可以利用更坚固和耐用的电动液压碎石术 (EHL) 探针。

and 40% larger biopsy samples

并且活检样本大40%

, that may improve both diagnostic accuracy rates and stone clearance in a single session.

，这样可以提高单次手术的诊断准确率和结石清除率。

“We are incredibly excited about our collaboration with Medtronic to bring an innovative solution that could improve the outcomes for patients with difficult pancreaticobiliary diseases,” said Jeremy Starkweather, CEO, Dragonfly™* Endoscopy. “We look forward to seeing the Dragonfly™* pancreaticobiliary system reimagine the way Cholangiopancreatoscopy procedures are performed.”.

“我们对与美敦力的合作感到无比兴奋，这将带来一种创新的解决方案，有望改善患有复杂胰胆疾病的患者的治疗效果，”蜻蜓™* 内窥镜首席执行官杰里米·斯塔克韦瑟表示。“我们期待看到蜻蜓™* 胰胆系统重新定义胆胰管镜手术的操作方式。”

“This collaboration underscores our commitment at Medtronic to leading innovation in gastroenterology, focused not only on patient outcomes but also on clinician satisfaction,' said Raj Thomas, president of the Medtronic Endoscopy business, which is part of the Medical Surgical portfolio. “We’re excited about the potential for the Dragonfly™* system to enhance procedural experiences for clinicians and ultimately improve patient care.”.

“这次合作突显了美敦力在胃肠病学领域引领创新的承诺，我们的关注点不仅在于患者的治疗效果，还包括临床医生的满意度，” 美敦力内窥镜业务部总裁、隶属于外科医疗产品组合的拉吉·托马斯表示，“我们对Dragonfly™*系统提升临床医生的操作体验并最终改善患者护理的潜力感到非常兴奋。”

Medtronic will introduce the Dragonfly™* system across selected U.S. academic and clinical centers beginning in 2025. This strategic distribution aligns with Medtronic’s dedication to advancing innovative medical technologies for improved patient care globally.

美敦力将于2025年开始在美国部分学术和临床中心推出Dragonfly™*系统。这一战略性分布体现了美敦力致力于推动创新医疗技术的发展，以提升全球患者护理水平。

About Medtronic

美敦力公司简介

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.

大胆思考。更果敢的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找并发现解决方案，勇敢地应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长寿命——团结了来自150多个国家的95,000多名充满热情的员工。

Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.

我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们广泛的知识、无尽的好奇心和帮助所有需要帮助的人的愿望，我们提供了创新的技术，每秒、每小时、每一天都在改变两个人的生活。

Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .

我们致力于推动以洞察力为导向的护理、以人为本的体验以及为我们的世界带来更好的结果，对我们有更多期待。在我们所做的每一件事中，我们都在创造非凡。欲了解有关美敦力的更多信息，请访问。